Drug Profile
Research programme: wide spectrum anti-cancer therapeutics - Admescope/Argon/ElexoPharm/PharmBioTec/Pharmacelsus
Alternative Names: WispATDrugLatest Information Update: 28 Feb 2018
Price :
$50
*
At a glance
- Originator Argon Pharma; ElexoPharm GmbH
- Class Small molecules
- Mechanism of Action Focal adhesion protein-tyrosine kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Feb 2018 No recent reports of development identified for research development in Cancer in Finland
- 28 Feb 2018 No recent reports of development identified for research development in Cancer in Germany
- 28 Feb 2018 No recent reports of development identified for research development in Cancer in Spain